Intuitive Surgical, Inc. (ISRG)
426.70
-1.16
(-0.27%)
USD |
NASDAQ |
Oct 16, 16:00
425.50
-1.20
(-0.28%)
After-Hours: 20:00
Intuitive Surgical Cash from Investing (Quarterly) : -26.60M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.60M |
| March 31, 2026 | -914.50M |
| December 31, 2025 | -209.40M |
| September 30, 2025 | 401.00M |
| June 30, 2025 | 260.70M |
| March 31, 2025 | 213.50M |
| December 31, 2024 | -1.264B |
| September 30, 2024 | -1.413B |
| June 30, 2024 | -467.10M |
| March 31, 2024 | -128.50M |
| December 31, 2023 | -1.044B |
| September 30, 2023 | -446.60M |
| June 30, 2023 | 557.60M |
| March 31, 2023 | 573.10M |
| December 31, 2022 | 574.80M |
| September 30, 2022 | 544.50M |
| June 30, 2022 | 466.20M |
| March 31, 2022 | -214.70M |
| December 31, 2021 | -641.00M |
| September 30, 2021 | -838.80M |
| June 30, 2021 | -384.70M |
| March 31, 2021 | -597.00M |
| December 31, 2020 | -334.30M |
| September 30, 2020 | -1.026B |
| June 30, 2020 | 536.70M |
| Date | Value |
|---|---|
| March 31, 2020 | -117.10M |
| December 31, 2019 | -406.20M |
| September 30, 2019 | -216.60M |
| June 30, 2019 | -222.70M |
| March 31, 2019 | -298.90M |
| December 31, 2018 | -486.30M |
| September 30, 2018 | -572.60M |
| June 30, 2018 | -44.30M |
| March 31, 2018 | 53.60M |
| December 31, 2017 | -315.80M |
| September 30, 2017 | -260.00M |
| June 30, 2017 | -353.80M |
| March 31, 2017 | 1.308B |
| December 31, 2016 | -309.00M |
| September 30, 2016 | -541.30M |
| June 30, 2016 | -237.20M |
| March 31, 2016 | -191.90M |
| December 31, 2015 | -413.10M |
| September 30, 2015 | -338.80M |
| June 30, 2015 | -9.90M |
| March 31, 2015 | -87.70M |
| December 31, 2014 | -203.50M |
| September 30, 2014 | -258.70M |
| June 30, 2014 | 513.60M |
| March 31, 2014 | -205.30M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp. | -639.00M |
| Zimmer Biomet Holdings, Inc. | -190.80M |
| Abbott Laboratories | -673.00M |
| Globus Medical, Inc. | -129.05M |
| Edwards Lifesciences Corp. | -193.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.061B |
| Cash from Financing (Quarterly) | -287.90M |
| Free Cash Flow | 3.223B |
| Free Cash Flow Per Share (Quarterly) | 2.654 |
| Free Cash Flow to Equity (Quarterly) | 948.40M |
| Free Cash Flow to Firm (Quarterly) | 948.40M |
| Free Cash Flow Yield | 2.10% |